LifeMD:Freedom Capital Maintains Buy Rating, Raises PT to $10 from $8

Thursday, Mar 12, 2026 1:31 pm ET1min read
LFMD--

LifeMD:Freedom Capital Maintains Buy Rating, Raises PT to $10 from $8

LifeMD:Freedom Capital Maintains Buy Rating, Raises PT to $10 from $8

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet